Literature DB >> 2649385

Haemagglutinating activity of Aeromonas spp. from different sources; attempted use as a typing system.

A M Elbashir1, S E Millership.   

Abstract

The haemagglutinating ability of 141 isolates of Aeromonas spp. for human, horse and guinea-pig erythrocytes was examined. Although the majority of isolates (136/141) agglutinated human group O erythrocytes, all the eight possible patterns of agglutination were observed. Haemagglutination of human group O erythrocytes, but not horse or guinea-pig, was associated with the ability to agglutinate yeast cells (Saccharomyces) and with aggregation in a low concentration of ammonium sulphate. Haemagglutinating ability was further characterized by reactions in the presence of mannose, galactose or fucose. All the possible patterns of inhibition with individual sugars were observed, but haemagglutination of human group O erythrocytes not inhibited by mannose, galactose or fucose was more common among isolates from patients with diarrhoea, and isolates producing a Vero cell cytotoxin than would be expected by chance. This might represent a virulence factor. When used as a typing system haemagglutination patterns did not correspond with the clustering of isolates expected on epidemiological grounds. Repeated subculturing resulted in a loss of agglutinating ability, an increase in the number of sugars inhibiting haemagglutination and an increase in the salt concentration required for aggregation. Haemagglutination did not seem to be useful as a means of typing aeromonads.

Entities:  

Mesh:

Year:  1989        PMID: 2649385      PMCID: PMC2249449          DOI: 10.1017/s0950268800029897

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Relationship of toxin production to species in the genus Aeromonas.

Authors:  M R Barer; S E Millership; S Tabaqchali
Journal:  J Med Microbiol       Date:  1986-12       Impact factor: 2.472

2.  Autoaggregating Yersinia enterocolitica express surface fimbriae with high surface hydrophobicity.

Authors:  A Faris; M Lindahl; A Ljungh; D C Old; T Wadström
Journal:  J Appl Bacteriol       Date:  1983-08

3.  The use of a biotyping system to investigate an unusual clustering bacteraemias caused by Aeromonas species.

Authors:  B D Cookson; E T Houang; J V Lee
Journal:  J Hosp Infect       Date:  1984-06       Impact factor: 3.926

4.  Esterase electrophoresis: a new epidemiological screening test for Aeromonas hydrophila hospital infection.

Authors:  B Picard; P Goullet
Journal:  J Hosp Infect       Date:  1984-09       Impact factor: 3.926

5.  O-serogrouping scheme for mesophilic Aeromonas strains.

Authors:  R Sakazaki; T Shimada
Journal:  Jpn J Med Sci Biol       Date:  1984 Oct-Dec

6.  Isolation of Aeromonas hydrophila from a metropolitan water supply: seasonal correlation with clinical isolates.

Authors:  V Burke; J Robinson; M Gracey; D Peterson; K Partridge
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

7.  Aeromonas-associated gastroenteritis.

Authors:  M Gracey; V Burke; J Robinson
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

8.  Serogrouping of motile Aeromonas species isolated from healthy and moribund fish.

Authors:  D Leblanc; K R Mittal; G Olivier; R Lallier
Journal:  Appl Environ Microbiol       Date:  1981-07       Impact factor: 4.792

9.  Toxin production by Aeromonas spp. from different sources.

Authors:  S E Millership; M R Barer; S Tabaqchali
Journal:  J Med Microbiol       Date:  1986-12       Impact factor: 2.472

10.  Hemagglutination patterns of Aeromonas spp. in relation to biotype and source.

Authors:  V Burke; M Cooper; J Robinson; M Gracey; M Lesmana; P Echeverria; J M Janda
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

View more
  1 in total

1.  Purification and characterization of Aeromonas sobria pili, a possible colonization factor.

Authors:  A Hokama; M Iwanaga
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.